Skip to main content

Roche dismisses report of funding for $15 billion BioMarin bid

Shares of BioMarin Pharmaceutical Inc. surged prior to the market's opening Thursday after a report that Genentech Inc...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.